Celcuity Inc.
(NASDAQ : CELC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Commercial Services » Miscellaneous Commercial Services
symbolcompany%chnglast%shortavg$volume
FLTFleetCor Technologies, Inc.
-1.16%216.283.3%$442.78m
ETSYEtsy, Inc.
-0.96%43.187.9%$169.13m
CPRTCopart, Inc.
0.57%59.914.5%$161.08m
EFXEquifax Inc.
-0.40%126.712.0%$146.89m
PRAHPRA Health Sciences, Inc.
-0.49%95.222.4%$142.68m
BZUNBaozun Inc Sponsored ADR Class A
-1.82%60.821.7%$130.77m
ZZillow Group, Inc. Class C
-0.61%61.4610.8%$113.45m
ITGartner, Inc.
-0.56%135.062.4%$92.69m
TRUTransUnion
-0.98%71.710.9%$91.20m
CDKCDK Global Inc
0.32%66.082.2%$90.26m
CTASCintas Corporation
-0.44%188.634.5%$82.80m
ULTIUltimate Software Group, Inc.
-2.66%267.8710.1%$63.64m
XRXXerox Corporation
-0.23%26.395.3%$59.50m
BCOBrink's Company
0.61%82.701.2%$55.65m
BAHBooz Allen Hamilton Holding Corporation Class A
-1.07%44.601.9%$52.10m

Company Profile

Celcuity, Inc. is cellular analysis company that is discovering new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. Its proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded in January 2012 by Brian Sullivan and Lance Laing and is headquartered in Minneapolis, MN.